FFCP PHASE2:Hg19::chr4:104119528..104119570,-
From FANTOM5_SSTAR
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Short description: | p2@CENPE |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_2_at_CENPE_5end |
Coexpression cluster: | C109_Reticulocytes_non_acute_Hodgkin_Burkitt_retinoblastoma_lymphoma |
Association with transcript: | 0bp_to_ENST00000265148, ENST00000380026, ENST00000394771, ENST00000503705, NM_001813, uc003hxb.1, uc003hxc.1_5end |
EntrezGene: | CENPE |
HGNC: | 1856 |
UniProt: | Q02224F8W957D6RBW0 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p2@CENPE |
---|
0
5
10
15
20
25
30
35
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 5.04e-34 | 235 |
disease of cellular proliferation | 5.84e-33 | 239 |
hematologic cancer | 1.11e-22 | 51 |
immune system cancer | 1.11e-22 | 51 |
organ system cancer | 2.45e-19 | 137 |
leukemia | 1.49e-17 | 39 |
cell type cancer | 2.04e-13 | 143 |
myeloid leukemia | 5.25e-13 | 31 |
carcinoma | 1.21e-09 | 106 |
lymphoma | 5.25e-07 | 10 |
Showing 1 to 10 of 10 entries